Collectively, these data support a protective role for NAMPT-Exo in modulating the progression of AS in the context of CXCR4 deficiency, potentially through anti-inflammatory, anti-calcific, or reparative mechanisms, warranting further mechanistic investigation and therapeutic exploration. This evidence concerns the gene CXCR4 and aortic stenosis.